The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions
Open accessAbstract
had no impact on blood counts or indices. Mutational burden of both genes correlated with X-inactivation skewing but no significant association with age-adjusted telomere length reduction was documented. The discordance between the high prevalence of mutations in these 2 genes and their limited biological impact raise the question of the potential role of dysregulated epigenetic modifiers in normal aging hematopoiesis, which may include support to failing hematopoiesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Various other systemic effects have been described in association with CH, including chronic obstructive pulmonary disease and other pulmonary disease [16,33,34]”
From Clonal hematopoiesis and inflammation – the perpetual cycle (2023) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Loss-of-function heterozygous mutations in epigenetic regulators DNMT3A (cytosine methyltransferase) and TET2 (methylcytosine dioxygenase) are the most frequently detected mutations in CHIP, accounting for about 50% to 60% and 10% to 30% of mutations found in CHIP carriers, respectively.1, 2, 3,7,8”
From Aging drives Tet2 +/− clonal hematopoiesis via IL-1 signaling (2023) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the context of CHIP, TET2 mutations show highest clonal expansion rates over time (with an estimated 10% annual growth rate compared with 5% of DNMT3A mutations7,8,10).”
From Aging drives Tet2 +/− clonal hematopoiesis via IL-1 signaling (2023) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Loss-of-function heterozygous mutations in epigenetic regulators DNMT3A (cytosine methyltransferase) and TET2 (methylcytosine dioxygenase) are the most frequently detected mutations in CHIP, accounting for about 50% to 60% and 10% to 30% of mutations found in CHIP carriers, respectively.1, 2, 3,7,8”
From Aging drives Tet2 +/− clonal hematopoiesis via IL-1 signaling (2023) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“are predicted to have high expansion rates (10% increase in mean VAF per year1, 2, 3,7)”
From Aging drives Tet2 +/− clonal hematopoiesis via IL-1 signaling (2023) · cites this paper as [7]
Experimental — accuracy not yet measured
The cited source says what the claim attributes to it.
In the citing paper
“many have noted that DNMT3A mutations confer little phenotype on steady state hematopoiesis (Buscarlet et al., 2017)”
From Chronic infection drives Dnmt3a-loss-of-function clonal hematopoiesis via IFNγ signaling (2021) · cites this paper as Buscarlet et al., 2017
In the citing paper
“CHIP itself does not denote a malignancy, nor is it associated with clinically significant alterations in blood counts 28,63.”
From Clonal hematopoiesis in human aging and disease (2019) · cites this paper as [63]
In the citing paper
“Other studies have found links between CHIP and chronic obstructive pulmonary disease (COPD) 37,63.”
From Clonal hematopoiesis in human aging and disease (2019) · cites this paper as [63]
In the citing paper
“However, CHIP was also strongly linked to smoking in these studies, so the result could be confounded by this association.”
From Clonal hematopoiesis in human aging and disease (2019) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
Telomere measurement by quantitative PCR
Cawthon, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.10.e47 · Cited by 3,550
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
Genovese, G., Kähler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F., Chambert, K., Mick, E., Neale, B. M., Fromer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409405 · Cited by 3,531
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
Steensma, D. P., Bejar, R., Jaiswal, S., Lindsley, R. C., Sekeres, M. A., Hasserjian, R. P., & Ebert, B. L. (2015) · Blood · doi:10.1182/blood-2015-03-631747 · Cited by 1,971
Age-related mutations associated with clonal hematopoietic expansion and malignancies
Xie, M., Lu, C., Wang, J., McLellan, M. D., Johnson, K. J., Wendl, M. C., McMichael, J. F., Schmidt, H. K., Yellapantula, V., Miller, C. A., et al. (2014) · Nature Medicine · doi:10.1038/nm.3733 · Cited by 1,874
Allen, R. C., Zoghbi, H. Y., Moseley, A., Rosenblatt, H. M., & Belmont, J. W. (1992) · PubMed · Cited by 1,683
The origin and evolution of mutations in acute myeloid leukemia
Welch, J. S., Ley, T. J., Link, D. C., Miller, C. A., Larson, D. E., Koboldt, D. C., Wartman, L. D., Lamprecht, T. L., Liu, F., Xia, J., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.023 · Cited by 1,575
Guralnik, J. M., Eisenstaedt, R. S., Ferrucci, L., Klein, H. G., & Woodman, R. C. (2004) · Blood · doi:10.1182/blood-2004-05-1812 · Cited by 1,450
Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia
Shlush, L. I., Zandi, S., Mitchell, A., Chen, W. C., Brandwein, J. M., Gupta, V., Kennedy, J. A., Schimmer, A. D., Schuh, A. C., Yee, K. W., et al. (2014) · Nature · doi:10.1038/nature13038 · Cited by 1,443
Cited by
Sorted by citations
Items 201–300 of 381
Kállai, A., Ungvari, A., Csabán, D., Őrfi, Z., Lehoczki, A., Harasztdombi, J., Yabluchanskiy, A., Benyó, Z., Szappanos, Á., Tarantini, S., et al. (2025) · GeroScience · doi:10.1007/s11357-025-01654-1 · Cited by 14
Studying clonal evolution of myeloid malignancies using induced pluripotent stem cells
Doulatov, S. R., & Papapetrou, E. P. (2020) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000620 · Cited by 15
DNA Methylation and Intra-Clonal Heterogeneity: The Chronic Myeloid Leukemia Model
Lebecque, B., Bourgne, C., Vidal, V., & Berger, M. G. (2021) · Cancers · doi:10.3390/cancers13143587 · Cited by 15
Opstad, T. B., Solheim, S., Pettersen, A. R., Kalstad, A. A., Arnesen, H., & Seljeflot, I. (2022) · Biomedicines · doi:10.3390/biomedicines10082027 · Cited by 16
L’hématopoïèse clonale : un concept émergent à la croisée des spécialités
Danlos, F., Papo, M., & Micol, J. (2019) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2019.05.005 · Cited by 19
Social, Behavioral, and Clinical Risk Factors Are Associated with Clonal Hematopoiesis
Young, C. D., Hubbard, A. K., Saint‐Maurice, P. F., Chan, I. C. C., Cao, Y., Tran, D., Bolton, K. L., Chanock, S. J., Matthews, C. E., Moore, S. C., et al. (2024) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-24-0620 · Cited by 13
Epigenetic roles in clonal hematopoiesis and aging kidney-related chronic kidney disease
Ogura, Y., & Mimura, I. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1281850 · Cited by 13
Emon, I. M., Al‐Qazazi, R., Rauh, M. J., & Archer, S. L. (2023) · Cells · doi:10.3390/cells12212528 · Cited by 14
Shannon, M. L., Heimlich, J. B., Olson, S., Debevec, A., Copeland, Z., Kishtagari, A., Vlasschaert, C., Snider, C. A., Silver, A. J., Brown, D. J., et al. (2024) · Blood Advances · doi:10.1182/bloodadvances.2023011510 · Cited by 13
Game of clones: Diverse implications for clonal hematopoiesis in lymphoma and multiple myeloma
Meier, J., Jensen, J. L., Dittus, C. E., Coombs, C. C., & Rubinstein, S. M. (2022) · Blood Reviews · doi:10.1016/j.blre.2022.100986 · Cited by 15
Savola, P., Bhattacharya, D., & Huuhtanen, J. (2022) · Seminars in Hematology · doi:10.1053/j.seminhematol.2022.07.004 · Cited by 14
Targeted, Amplicon-Based, Next-Generation Sequencing to Detect Age-Related Clonal Hematopoiesis
Snetsinger, B., Ferrone, C. K., & Rauh, M. J. (2019) · Methods in molecular biology · doi:10.1007/7651_2019_216 · Cited by 13
Single cell mutational profiling delineates clonal trajectories in myeloid malignanciesPreprint
Miles, L. A., Bowman, R. L., Merlinsky, T. R., Csete, I. S., Ooi, A. T., Durruthy-Durruthy, R., Bowman, M., Famulare, C. A., Patel, M. A., Méndez, P., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.07.938860 · Cited by 14
Majeti, R., Jamieson, C. H. M., Pang, W. W., Jaiswal, S., Leeper, N. J., Wernig, G., & Weissman, I. L. (2022) · Annual Review of Medicine · doi:10.1146/annurev-med-042420-104436 · Cited by 12
Shabashvili, D. E., Feng, Y., Kaur, P., Venugopal, K., & Guryanova, O. A. (2022) · Experimental Hematology · doi:10.1016/j.exphem.2022.03.008 · Cited by 14
The role of genomics and genetics in pulmonary arterial hypertension
Swietlik, E. M., Gräf, S., & Morrell, N. W. (2020) · Global Cardiology Science and Practice · doi:10.21542/gcsp.2020.13 · Cited by 14
Brunet, T., Berutti, R., Dill, V., Hecker, J. S., Choukair, D., Andres, S., Deschauer, M., Diehl‐Schmid, J., Krenn, M., Eckstein, G., et al. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac034 · Cited by 11
DNA (Hydroxy)Methylation in T Helper Lymphocytes
Monticelli, S. (2019) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2019.01.009 · Cited by 12
Insights into novel emerging epigenetic drugs in myeloid malignancies
Chandhok, N. S., & Prébet, T. (2019) · Therapeutic Advances in Hematology · doi:10.1177/2040620719866081 · Cited by 11
Age-dependent association of clonal hematopoiesis with COVID-19 mortality in patients over 60 years
Pozo‐Valero, M. D., Cortón, M., López‐Rodríguez, R., Mahíllo, I., Ruiz‐Hornillos, J., Mínguez, P., Villaverde, C., Pérez-Tomás, M. E., Barreda‐Sánchez, M., Mancebo, E., et al. (2022) · GeroScience · doi:10.1007/s11357-022-00666-5 · Cited by 11
Chua, T. H., & Takano, A. M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11216290 · Cited by 11
González‐Gil, C., Morgades, M., Lopes, T., Fuster‐Tormo, F., García-Chica, J., Zhao, R., Montesinos, P., Torrent, A., Díaz‐Beyá, M., Coll, R., et al. (2022) · Haematologica · doi:10.3324/haematol.2022.281196 · Cited by 11
Clinical and Therapeutic Implications of Clonal Hematopoiesis
Petrone, G. E. M., Turker, I., Natarajan, P., & Bolton, K. L. (2024) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-120722-100409 · Cited by 11
Current Aspects of Clonal Hematopoiesis: Implications for Clinical Diagnosis
Karner, K. H., George, T. I., & Patel, J. L. (2019) · Annals of Laboratory Medicine · doi:10.3343/alm.2019.39.6.509 · Cited by 11
Mayo Clinic experience with 1123 adults with acute myeloid leukemia
Begna, K. H., Ali, W. R., Gangat, N., Elliott, M. A., Al‐Kali, A., Litzow, M. R., Hook, C. C., Wolanskyj, A. P., Hogan, W. J., Patnaik, M. M., et al. (2021) · Blood Cancer Journal · doi:10.1038/s41408-021-00435-1 · Cited by 11
Pseudo-mutant P53 is a unique phenotype of DNMT3A-mutated pre-leukemia
Tuval, A., Brilon, Y., Azogy, H., Moskovitz, Y., Biezuner, T., Leshkowitz, D., Salame, T. M., Minden, M. D., Tal, P., Rotter, V., et al. (2022) · Haematologica · doi:10.3324/haematol.2021.280329 · Cited by 12
Understanding the impact of mitochondrial DNA mutations on aging and carcinogenesis (Review)
Kobayashi, H., & Imanaka, S. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5559 · Cited by 11
Wang, H.-Y., Ho, C., Lin, Y., Liao, W., Chen, C., Shih, J., & Yu, C. (2024) · JCO Precision Oncology · doi:10.1200/po.23.00314 · Cited by 10
Clonal haematopoiesis of emerging significance
Hammond, D. E., & Loghavi, S. (2021) · Pathology · doi:10.1016/j.pathol.2021.02.005 · Cited by 10
The vicious and virtuous circles of clonal hematopoiesis
Furer, N., Kaushansky, N., & Shlush, L. I. (2021) · Nature Medicine · doi:10.1038/s41591-021-01396-5 · Cited by 10
Nam, A. S., Dusaj, N. N., Izzo, F., Murali, R., Myers, R. M., Mouhieddine, T. H., Sotelo, J., Benbarche, S., Waarts, M. R., Gaiti, F., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.14.476225 · Cited by 10
Diagnosis of Myelodysplastic Syndromes: From Immunological Observations to Clinical Applications
Simoni, Y., & Chapuis, N. (2022) · Diagnostics · doi:10.3390/diagnostics12071659 · Cited by 9
Loss of Dnmt3a impairs hematopoietic homeostasis and myeloid cell skewing via the PI3Kinase pathway
Palam, L. R., Ramdas, B., Pickerell, K., Pasupuleti, S. K., Kanumuri, R., Cesarano, A., Szymanski, M., Selman, B., Davé, U. P., Sandusky, G. E., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.163864 · Cited by 9
Bae, S.-G., Kim, H., Kim, M. Y., Kim, D. H., Shin, S.-I., Ahn, J., & Park, J. (2023) · Molecules and Cells · doi:10.14348/molcells.2023.0093 · Cited by 9
Heumüller, A., Wehrle, J., Stosch, J. M., Niemöller, C., Bleul, S., Waterhouse, M., Uhl, D., Metzeler, K. H., Lübbert, M., Duyster, J., et al. (2019) · Bone Marrow Transplantation · doi:10.1038/s41409-019-0575-4 · Cited by 9
Lang, A., Whongsiri, P., Yılmaz, M., Lautwein, T., Petzsch, P., Greife, A., Güneş, Ç., Köhrer, K., Niegisch, G., Hoffmann, M. J., et al. (2020) · Cancers · doi:10.3390/cancers12041023 · Cited by 9
Induced pluripotent stem cell models of myeloid malignancies and clonal evolution
Reilly, A., & Doulatov, S. R. (2021) · Stem Cell Research · doi:10.1016/j.scr.2021.102195 · Cited by 9
Putative homeostatic role of cancer driver mutations
Venkatachalam, A., Pikarsky, E., & Ben‐Neriah, Y. (2021) · Trends in Cell Biology · doi:10.1016/j.tcb.2021.07.002 · Cited by 9
Implications of Clonal Hematopoiesis in Hematological and Non-Hematological Disorders
Zhang, Q., Yim, R., Lee, P., Chin, L., Li, V., & Gill, H. (2024) · Cancers · doi:10.3390/cancers16234118 · Cited by 10
Hajishengallis, G. (2025) · Journal of Periodontology · doi:10.1002/jper.70040 · Cited by 9
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC
Testa, U., Castelli, G., & Pelosi, E. (2022) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2022.069 · Cited by 9
Clonal Hematopoiesis: Origins and determinants of evolution
Mendez, L., & Patnaik, M. M. (2023) · Leukemia Research · doi:10.1016/j.leukres.2023.107076 · Cited by 8
Asaulenko, Z. P., Spiridonov, I. N., Барам, Д. В., & Krivolapov, Y. А. (2023) · Russian Journal of Archive of Pathology · doi:10.17116/patol20238505136 · Cited by 8
The role of clonal progression leading to the development of therapy-related myeloid neoplasms
Guarnera, L., Pascale, M. R., Hajrullaj, H., Cristiano, A., Mallegni, F., Onorato, A., Voso, M. T., & Fabiani, E. (2024) · Annals of Hematology · doi:10.1007/s00277-024-05803-y · Cited by 10
Clonal hematopoiesis of indeterminate potential: contribution to disease and promising interventions
Li, C., Zhang, C., & Li, X. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05261-8 · Cited by 8
Late Onset of Chronic Granulomatous Disease Revealed by Paecilomyces lilacinus Cutaneous Infection
Lemaigre, C., Suárez, F., Martellosio, J.-P., Barbarin, C., Brunet, K., Chomel, J., Hainaut, E., Rammaert, B., Roblot, F., & Torregrosa‐Diaz, J. M. (2021) · Journal of Clinical Immunology · doi:10.1007/s10875-021-01140-1 · Cited by 11
Uddin, M. M., Nguyen, N. Q., Yu, B., Brody, J. A., Pampana, A., Nakao, T., Fornage, M., Bressler, J., Sotoodehnia, N., Weinstock, J. S., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1463822/v1 · Cited by 9
Yim, J., Koh, J., Kim, S., Song, S. G., Bae, J. M., Yun, H., Sung, J., Kim, T. M., Park, S., & Jeon, Y. K. (2022) · PubMed Central · doi:10.1097/pas.0000000000001859 · Cited by 7
Clonal hematopoiesis, cardiovascular disease and cancer treatment-induced cardiotoxicity
Zhang, N., Tian, X., Sun, D.-K., Tse, G., Xie, B., Zhao, Z., & Liu, T. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.02.007 · Cited by 7
Clonal haematopoiesis - a novel entity that modifies pathological processes in elderly
Belotserkovskaya, E., Golotin, V., Uyanik, B., & Demidov, O. N. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01590-z · Cited by 8
Clonal expansion in normal tissues
Maeda, H., & Kakiuchi, N. (2024) · Cancer Science · doi:10.1111/cas.16183 · Cited by 7
Somatic selection of poorly differentiating variant stem cell clones could be a key to human ageing
Bodmer, W. F., & Crouch, D. J. M. (2020) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2020.110153 · Cited by 8
Zuriaga, M. A., & Fuster, J. J. (2021) · Circulation Journal · doi:10.1253/circj.cj-21-0505 · Cited by 6
Evaluation of clonal hematopoiesis in pediatric ADA-SCID gene therapy participants
White, S. L., Lee, T. D., Toy, T. L., Carroll, J., Polsky, L. R., Fernandez, B. C., Davila, A., Kohn, D. B., & Chang, V. Y. (2022) · Blood Advances · doi:10.1182/bloodadvances.2022007803 · Cited by 7
Gagnon, M.-F., Provost, S., Sun, M., Ayachi, S., Buscarlet, M., Mollica, L. R., Szuber, N., Dubé, M., & Busque, L. (2023) · Blood Advances · doi:10.1182/bloodadvances.2022008793 · Cited by 8
Clinical implications of myeloid malignancy‑related somatic mutations in aplastic anemia
Liu, L., Zhang, D., Fu, Q., Wang, J., Yu, J., Chen, D., Wang, F., Guo, R., Xie, X., Jiang, Z., et al. (2023) · Clinical and Experimental Medicine · doi:10.1007/s10238-023-01067-4 · Cited by 9
Chicken or Egg: Is Clonal Hematopoiesis Primarily Caused by Genetic or Epigenetic Aberrations?
Cypris, O., Božić, T., & Wagner, W. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00785 · Cited by 8
Carraway, H. E., & LaFramboise, T. (2020) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2020.101191 · Cited by 7
Yun, J., Youn, Y. C., & Kim, H. R. (2024) · Annals of Laboratory Medicine · doi:10.3343/alm.2024.0086 · Cited by 6
Cell‐free DNA‐associated multi‐feature applications in cancer diagnosis and treatment
Zhang, X., Li, J., Lan, X., & Li, J. (2024) · Clinical and Translational Discovery · doi:10.1002/ctd2.280 · Cited by 6
Bhowmik, S., Bose, A., & Sengupta, A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1660709 · Cited by 8
Stein, C. M., Hablesreiter, R., Christen, F., Löwe, P., Torre, C. F., Kopp, K., Locher, B. N., Nitsch, L., Altwasser, R., Kerschbaum, J. F., et al. (2025) · Leukemia · doi:10.1038/s41375-025-02823-z · Cited by 6
Wei, Y., Kanagal‐Shamanna, R., Zheng, H., Bao, N., Lockyer, P. P., Class, C. A., Darbaniyan, F., Lü, Y., Lin, K., Yang, H., et al. (2022) · Leukemia · doi:10.1038/s41375-022-01605-1 · Cited by 6
Rodriguez, J. E., Baldini, C., Bayle, A., Pagès, A., Danlos, F., Vasseur, D., Rouleau, É., Lacroix, L., de Castro, B. A., Goldschmidt, V., et al. (2024) · JCO Precision Oncology · doi:10.1200/po.23.00631 · Cited by 6
Clinical manifestations of clonal hematopoiesis: What has SF3B1-mutant MDS taught us?
Todisco, G., Moura, P. L., & Hellström‐Lindberg, E. (2022) · Seminars in Hematology · doi:10.1053/j.seminhematol.2022.08.002 · Cited by 5
Clonal Hematopoiesis and Cardiovascular Risk: Atherosclerosis, Thrombosis, and beyond
Izzi, B., & Fuster, J. J. (2024) · Hämostaseologie · doi:10.1055/a-2219-6410 · Cited by 6
Recipient clonal hematopoiesis in allogeneic bone marrow transplantation for lymphoid malignancies
Imus, P. H., Paşca, S., Tsai, H., Aljawai, Y. M., Cooke, K. R., Walston, J. D., Gocke, C. D., Varadhan, R., Jones, R. J., & Gondek, L. P. (2024) · Blood Advances · doi:10.1182/bloodadvances.2023011761 · Cited by 6
Clonal haematopoiesis associates with distinct cytometric changes of red blood cells and platelets
Salzbrunn, J. B., van Zeventer, I. A., de Graaf, A. O., Klatte, S., van Pelt, L. J., Kamphuis, P., van Bergen, M. G. J. M., Dinmohamed, A. G., van der Reijden, B. A., Linssen, J., et al. (2025) · British Journal of Haematology · doi:10.1111/bjh.70031 · Cited by 5
Connor, A., Starnino, L., Busque, L., Tardif, J., Bourgoin, V., Dubé, M., Busseuil, D., & D’Antono, B. (2022) · Psychological Medicine · doi:10.1017/s0033291722003543 · Cited by 7
Clonal hematopoiesis in large granular lymphocytic leukemia
Kawashima, N., Gurnari, C., Bravo‐Pérez, C., Kubota, Y., Pagliuca, S., Guarnera, L., Williams, N. D., Durmaz, A., Ahmed, A., Dima, D., et al. (2024) · Leukemia · doi:10.1038/s41375-024-02460-y · Cited by 5
Hoermann, G. (2022) · Journal of Laboratory Medicine · doi:10.1515/labmed-2022-0050 · Cited by 5
Micronutrient regulation of the DNA methylome
Leesang, T. E., Lyon, P. D., Pinzone, J., & Cimmino, L. (2024) · Frontiers in Epigenetics and Epigenomics · doi:10.3389/freae.2024.1409355 · Cited by 5
Li, W., Xiao, X., Jing, X., Zheng, Y., Sun, X., Bai, W., Li, M., Luo, M., & Xiao, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1607778 · Cited by 4
Moyen, T. B., Tomaz, V., Cortês, L. G. F., Rosa, S., Santos, F. P. D. S., Hamerschlak, N., Puga, R., Reis, R. D. S., Petroni, R. C., Silveira, C. N., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-24475-w · Cited by 4
Carter, P., Kitt, L., Rodgers, A., Figg, N. L., Zhou, A., Zhu, C., Wang, Z., Libby, P., Burgess, S., Vassiliou, G. S., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.200334 · Cited by 5
Ten-Eleven Translocation 1 and 2 Enzymes Affect Human Skin Fibroblasts in an Age-Related Manner
Kołodziej, P., Borkowska, J., Domaszewska-Szostek, A., Bujanowska, O., Noszczyk, B. H., Krześniak, N. E., Stańczyk, M., & Puzianowska‐Kuźnicka, M. (2023) · Biomedicines · doi:10.3390/biomedicines11061659 · Cited by 4
Exploring the intricate cross-talk between clonal expansion and the bone marrow niche
Ngo, S. D., Papazoglou, D., Encabo, H. H., & Bonnet, D. A. (2024) · Frontiers in Hematology · doi:10.3389/frhem.2024.1334807 · Cited by 4
Impact of cytotoxic therapy on clonal hematopoiesis and myeloid neoplasms in breast cancer patients
Kim, H., Jin, H., Kim, J.-Y., Hong, Y. J., & Lee, J. K. (2024) · Medicine · doi:10.1097/md.0000000000040540 · Cited by 5
Zuriaga, M. A., & Fuster, J. J. (2025) · Diabetologia · doi:10.1007/s00125-025-06393-8 · Cited by 6
Applications of ctDNA testing to monitor and detect residual disease in breast cancer
Chen, J. H., Geng, Y., & Lucci, A. (2025) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2025.2498545 · Cited by 6
Jamin, R. N., Al‐Kassou, B., Kleuker, T., Shamekhi, J., Bartsch, B., Ackerschott, A., Zaidi, M. A., Billig, H., Graef, C. M., Kelm, M., et al. (2025) · Clinical Research in Cardiology · doi:10.1007/s00392-025-02658-9 · Cited by 4
Clonal hematopoiesis of indeterminate potential and atrial fibrillation
Liu, J., Zhang, N., Teng, G., Tse, G., Bai, J., Lip, G. Y. H., & Liu, T. (2025) · Heart Rhythm · doi:10.1016/j.hrthm.2025.05.011 · Cited by 4
Fan, W., Yeh, J., Hsieh, L., Tsai, M., Ho, M.-Y., Huang, Y., Hsieh, I.-C., Wen, M., & Wang, C.-Y. (2025) · Human Genomics · doi:10.1186/s40246-025-00757-2 · Cited by 4
Barabino, S. M. L., Citterio, E., & Ronchi, A. E. (2021) · Cancers · doi:10.3390/cancers13153753 · Cited by 4
Clonal hematopoiesis and its role in the development of hematological diseases
Петинати, Н. А., & Дризе, Н. И. (2021) · Гематология и трансфузиология · doi:10.35754/0234-5730-2021-66-4-580-592 · Cited by 5
Clonal hematopoiesis and atherosclerotic cardiovascular disease: A primer
Zuriaga, M. A., & Fuster, J. J. (2021) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2021.09.006 · Cited by 4
Clones of aging: When better fitness can be dangerous
Marongiu, F., Cheri, S., & Laconi, E. (2023) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2023.151340 · Cited by 4
Regulators of clonal hematopoiesis and physiological consequences of this condition
Park, E., Evans, M. A., & Walsh, K. X. (2023) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2023.39 · Cited by 4
Belotserkovskaya, E., Zaikova, E. K., Petukhov, A., Demidov, O. N., Levchuk, K., Budaeva, I. G., Zaytsev, D., Rogovaya, Y. D., Shatilova, A. A., Bogdanov, K. V., et al. (2021) · Clinical oncohematology · doi:10.21320/2500-2139-2021-14-1-13-21 · Cited by 4
Dynamic Clonal Hematopoiesis and Functional T-cell Immunity in a Super-centenarianPreprint
van den Akker, E. B., Makrodimitris, S., Hulsman, M., Brugman, M. H., Nikolic, T., Bradley, T., Waisfisz, Q., Baas, F., Jakobs, M. E., de Jong, D., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/788752 · Cited by 4
Therapy-selected clonal hematopoiesis and its role in myeloid neoplasms
Jahn, J., Diamond, B. T., Hsu, J., Montoya, S., Totiger, T. M., Landgren, O., Maura, F., & Taylor, J. (2023) · Leukemia Research · doi:10.1016/j.leukres.2023.107020 · Cited by 3
Reed, S. C., Potts, C. R., Luo, L. Y., Davidson, B. A., Bergman, R. E., Kemp, J. D. J., Fox, E. K., Thomas, B. A., Ha, L., Arora, V. K., et al. (2025) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-25-2009 · Cited by 5
Nadar, S., Dohadwala, T. K., Kumaresan, N., Ahamed, S. I., & Fatima, S. (2025) · Clinical Hematology International · doi:10.46989/001c.146275 · Cited by 5
Obrębski, T., Maleszewska, M., Dunin-Horkawicz, S., & Malik, A. R. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.111267 · Cited by 5
Malkots, B., Stamatiou, I., Panagiotopoulos, E., Inglezou, L., Sakka, V., Vrachiolias, G., Misidou, C., Spanoudakis, E., Kotsianidis, Ι., & Liapis, K. (2026) · Cancers · doi:10.3390/cancers18091326 · Cited by 3
Epigenetic Abnormalities in Acute Myeloid Leukemia and Leukemia Stem Cells
Xu, J., Hang, X., Wu, B., Chen, C., & Liu, Y. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-7342-8_8 · Cited by 3
Steensma, D. P. (2021) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2021.101327 · Cited by 3
Aref, S., Sallam, N. M., El-Aziz, S. A., Salama, O., Ashwah, S. A., & Ayed, M. B. (2022) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2022.23.12.4299 · Cited by 3
MBD4: guardian of the epigenetic galaxy
Busque, L., & Godley, L. A. (2018) · Blood · doi:10.1182/blood-2018-08-867044 · Cited by 3
Hunter, N. B., Croessmann, S., Cravero, K., Shinn, D., Hurley, P. J., & Park, B. H. (2020) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2019.7381 · Cited by 3
Metadata
- Authors
- Buscarlet, M., Provost, S., Zada, Y. F., Barhdadi, A., Bourgoin, V., Lépine, G., Mollica, L., Szuber, N., Dubé, M.-P., & Busque, L.
- Affiliations
- Hôpital Maisonneuve-Rosemont (CA)
- Montreal Heart Institute (CA)
- ORCID
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2017-08-10
- Volume
- 130
- Issue
- 6
- Pages
- 753-762
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2728241634
- Cited by
- 383
- References
- 50
- Citations by year
- 2026: 22 · 2025: 34 · 2024: 37 · 2023: 47 · 2022: 59 · 2021: 55 · 2020: 46 · 2019: 40 · 2018: 34 · 2017: 6
- FWCI
- 26.24
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Concordia University
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- DNMT3A, TET2, clonal hematopoiesis, somatic mutations, X-inactivation skewing, telomere length, epigenetic regulators, genetic susceptibility, mutational burden
- MeSH terms
- DNA Methyltransferase 3A, Age Factors, Aged, Aged, 80 and over, Aging, Blood Cell Count, Clone Cells, DNA (Cytosine-5-)-Methyltransferases, DNA-Binding Proteins, Female, Hematopoiesis, Humans, Male, Middle Aged, Mutation, Proto-Oncogene Proteins, Cohort Studies, Hematologic Neoplasms, Genetic Predisposition to Disease, Dioxygenases, X Chromosome Inactivation, High-Throughput Nucleotide Sequencing, Telomere Homeostasis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
